In this study we systematically investigated the cellular distribution, immunohistochemical phenotype, and mucosal disposal function of macrophages in the lamina propria of the human gastrointestinal mucosa (lamina propria macrophages; LPMs). In all tissues examined, most of these LPMs accumulated beneath the epithelial layer that covered the apex of the lamina propria of the mucosa. These cells expressed normal levels of " n o n macrophage markets such as CD68, LN5, lysozyme, ferritin, and al-anti-chymotrypsin. In addition, they expressed high levels of 25F9 (a marker for a certain subpopulation of macrophages), MHC Class I1 molecules, and CD74 (MHC Class 11-associated invariant chain). Interestingly, LPMs possessed some epithelial cell-associated antigens such as cytokemtin, carcinoembryonic antigen (CEA), and Bet-Ep4 in their cytoplasm. Ultrastructurally, these antigens were associated with cellular debris ingested by LPMs, which were recognized as apoptotic fcagments by in situ end-labeling. Furthermore, double positivelabeled granules were seen in LPMs by double staining for epithelial cell-associated antigens and in situ end-labeling. These observations suggest that one of the major functions of LPMs is the disposal of apoptotic epithelial cells and that LPMs may be involved in the regulation of mumsal epithelial renewal. ( J Hisrochem Cytocbem 44:721-731, iw) 
Introduction
It is well known that the lamina propria of the human gastrointestinal (GI) mucosa contains large numbers of macrophages and related cells (1, 2) . These lamina propria macrophages (LPMs) are believed to play an important role in mucosal immunity, including the elimination of exogenous pathological antigens (3,4) and in antigen presentation (5, 6) , enhancement of immunoglobulin production by mononuclear cells ( 7 ) , and immunoregulatory properties (8) . In addition, human intestinal macrophages contribute to production of a novel mucin secretagogue (9) . However, details of the biological functions of these cells have not yet been fully defined.
It has recently been reported that LPMs are involved in the disposal system of the intestinal mucosa in certain experimental animals (10,ll) . One study has indicated that human LPMs phagocytose nuclear debris (12) , although it has not been confirmed that LPMs ingest epithelial cell debris in the human GI tract. In the present study, we examined the possibility that human LPMs may be involved in the disposal system for mucosal epithelial cells, by both light and electron microscopic immunohistochemistry and in situ end-labeling for detection of apoptotic cells. Furthermore, we invesigated systematically the cellular distribution of LPMs and their immunohistochemical phenotype and compared them with macrophages in other organs. These observations contribute further to elucidation of the cellular mechanisms that underlie mucosal physiology, immunology, and pathology.
Materials and Methods

Tissue Specimens
The following specimens were examined: gastric mucosa (n = 15), duodenal mucosa (n = 8). ileal mucosa (n = 9). colon mucosa (n = 16). and rectal mucosa (n = 10). These were obtained from organs surgically resected because of gastric or colorectal cancer, or from endoscopic biopsy specimens. From four patients who underwent endoscopic cramination, specimens of all tissues mentioned above were taken by biopsy. Any specimens that exhibited significant pathological changes were excluded so as to obtain more physiologically normal materials. In addition, mucosal specimens were obtained from fetuses autopsied at gestational ages of 19, 20, 30, and 32 weeks to examine the fetal GI. For comparison, liver (n = 4). spleen (n = 3), lung (n = 4). and reactive lymph nodes (n = 7). obtained during surgery or autopsy, were also examined.
Fimtion
Most tissues were fixed in 10% formalin and processed routinely to obtain conventional paraffin sections. In some cases, tissues were also fixed in 1.25% glutaraldehyde for conventional electron microscopic observations or in periodate-lysine-paraformaldehyde (PLP) solution (13) containing 4% paraformaldehyde for sensitive immunohistochemistry or immunoelectron microscopic observation. Surgically resected or endoscopically biopsied specimens were fixed soon after resection. The materials from autopsied patients were fixed within 3 hr after death. We obtain 131 formalin-fixed, 110 PLP-fixed, and 10 glutaraldehyde-fixed specimens in total. 
Antibodies
The monoclonal and polyclonal antibodies employed as primary antibodies are listed in Table 1 . Isotype-matched antibodies of inappropriate specificity or normal serum were used as controls.
Light Microscopic Observation and Immunohistochemical Labeling
Formalin-fued, Paraffii-embedded Materials. Sections from paraffinembedded tissues were stained with hematoxylin and eosin (HE) for conventional microscopic observation. Immunohistochemical labeling of the paraffin sections was mostly achieved with the avidin-biotin-peroxidase method, as follows. The sections were dewaxed in xylene, hydrated in a graded ethanol series, and submerged in methanol with 0.5% H202 to In a microwave oven, sections were irradiated for 10 min (twice for 5 min) at 95% power output (equivalent 600 W) and buffer temperature was set to 95 'C through the built-in thermocouple, according to Cattoretti's method (14) . They were then incubated with 2 % skim milk/PBS for 15 min at ambient temperature to block any nonspecific binding of the antibodies. After washing in PBS, they were incubated with each primary antibody in moist boxes at 4'C overnight. Next day, the sections were rinsed in PBS at least three times, and further processed for immunohistochemistry by the avidin-biotin-peroxidase method (15) using an SAB-Po kit (Nichirei; Tokyo, Japan). Finally, the peroxidase activity was developed in 0.03% diaminobenzidine (DAB)/Tris-HCl solution (pH 7.6) as described by Graham and Karnovsky (16) . The sections were counterstained with hematoxylin, dehydrated in a graded series of ethanol dilutions, cleared in xylene, and mounted with Permount (sP15-100: Fisher Scientific, Fair Lawn, NJ) for light microscopic observations.
~~~~~
Fixation and
PLFfixed Frozen Materials. PLP-fixed tissues were washed in PBS containing 5 % sucrose for 4 hr, then in PBS containing 10% sucrose for 4 hr, in PBS containing 20% sucrose for 4 hr, and finally in PBS containing 20% sucrose and 5 % glycerin for 30 min. The tissues were then embedded in OCT compound (Tissue-Tek Miles, Elkhart, IN), snap-frozen with liquid nitrogen, and stored at -8O'C. These frozen tissues were cut by cryostat (Bright OTF Cryostat; Bright, Huntingdon. UK) into 5-pm-thick sections. The sections were labeled by the indirect immunoperoxidase method to detect sensitive antigens, which had been destroyed during formalin fixation and the following process to obtain routine paraffin sections, as described previausly. Briefly, the cryostat sections were incubated with 5 mM periodate solution to block endogenous peroxidase activity, followed by incubation with 2% skim milk in PBS for 15 min to block any nonspecific binding of the antibodies. They were then incubated with each primary antibody overnight at 4'C. Next day, the sections were washed in PBS and incubated with peroxidase-conjugated secondary antibody [peroxidaseconjugated affinity-purified F(ab)z fragment of goat anti-mouse IgG + IgM (heavy and light chain specific)] (Jackson ImmunoResearch; West Grove, PA) for 2 hr at ambient temperature. After washing, they were developed in DAB solution, counterstained with hematoxylin, dehydrated, cleared, and mounted as described above.
Electron Microscopic Observation and Immunohistochemical Labeling
Conventional Transmisson Electron Microscopic (TEM) Observation. For conventional TEM observation, glutaraldehyde-fuced tissues were thoroughly washed in 0.1 M cacodylate buffer (pH 7.4) and postfixed in 1% os04 for 2 hr at 4'C. They were then dehydrated in a graded ethanol series, followed by propylene oxide, and embedded in Epon 812-Araldite. The appropriate areas were selected by LM observation of semithin (1-wm thickness) sections and then ultrathin sections were obtained with an ultramicrotome (Porter-Blum MT-1; Sorvall, Newtown, CT). After double electron staining with uranyl acetate and lead citrate, the sections were observed with an electron microscope (Zeiss EM109; Carl Zeiss, Oberkochen, Germany) at 80 kV.
Immunoelectron Microscopic Observation. To evaluate cellular labeling with the above-mentioned antibodies at greater resolution, PLP-fixed tissues were prepared for TEM as described previously (17) . Briefly, some portions of the PLP-fixed tissues were washed thoroughly in PBS, embedded in 4% Noble agar to maintain the appropriate orientation of the tissues, and cut into 50-pm-thick sections with a DTK-100 Micro-slicer (DSK;
Osaka, Japan). The sections were incubated oxmight at 4% in 5% BSA-PBS solution to block any nonspecific binding of the antibodies. Sections were then incubated for 24-48 hr at 4'C in each primary antibody. After washing for 1-3 hr in PBS, the sections were incubated for 24 hr at 4'C with the peroxidase-conjugated secondary antibody. After 1-3-hr washing in PBS. they were further fixed with glutaraldehyde solution for 20 min at ambient temperature. They were washed in PBS and Tris-HC1 buffer several times, incubated with 0.03% DAB in 0.05 M %is-HC1 buffer for 1 hr at ambient temperature, and then for an additional 30 min in the presence of 0.01% H202 to develop the peroxidase activity. To select appropriate areas for EM, the sections were initially mounted in buffer on glass slides and examined by LM. The slides were subsequently disassembled and the appropriate areas wee cut out with razor blades under microscopic observation and were processed as described for conventional EM observation. The ultrathin sections were observed without counterstaining.
In Situ End-labeling for Detection of Apoptotic Cells
To detect cells undergoing apoptosis, in situ end-labeling using the Apop-Tag detection kit (S7100-kit; Oncor, Gaithersburg, MD) was performed on conventional paraffin sections. Briefl~ the sections were dewaxed, dehydrated, then pretreated with proteinase K (20 pglml) at ambient temperature for 15 min. After washing they were incubated with PBS containing 2% H202 for 5 min to block endogenous peroxidase activity. They were then incubated with reaction buffer containing terminal deoxynucleotidyl transferase (TdT) and digoxigenin-labeled dUTP for 1 hr at 37'C. After washing in stopwash buffer, the slides were incubated with peroxidase-conjugated sheep anti-digoxigenin antibody for 5 min at ambient temperature. The peroxidase activity was developed in 3-amino-9-ethylcarbazole (AEC) substrate (Dakopatts; Copenhagen, Denmark). The slides were washed in water and mounted in Aquatm (Merck; Darmstadt, Germany) without counterstaining. As a negative control, TdT was omitted in the above- 
Restaining with CD68 Afier Ber-Ep4
Conventional formalin-fixed paraffin sections of colon mucosa were subjected to this staining procedure. The sections were first labeled with an antibody against epithelial cell-associated antigen Ber-Ep4 by the indirect immunoperoxidase method, as mentioned above. The peroxidase activity was developed with DAB solution and appeared as a brown deposit. Sections were counterstained with hematoxylin and mounted in Permount. After LM observation they were washed in xylene to remove the Permount, rehydrated in a graded ethanol series. and washed in PBS. The second labeling was performed by the direct method using the peroxidase-conjugated macrophage-associated antigen CD68 (Dakopatts EPOS anti-human macrophage, CD68/HRP, clone PG-MI). The reactivity of CD68 was developed as red coloration in ACE solution. The slides were finally washed in water and mounted in Aquatex.
Double Staining by In Situ End-labeling for Apoptotic Cells and Immunohistochemistry for Epithelial Cell-associated Antigens
To examine the possibility that LPMs could ingest apoptotic epithelial cells, double staining using in situ end-labeling and immunohistochemical labeling of epithelial cell-associated antigens was performed. Conventional formalin-fixed paraffin sections of colon mucosa were employed. The sections were first labeled with antibodies against epithelial cell-associated antigens such as carcinoembryonic antigen (CEA), Ber-Ep4, and cytokeratin, using the indirect immunoperoxidase method as mentioned above. The peroxidase activity was developed in DAB solution as a brown stain. Subsequently. in situ end-labeling for apoptosis using the ApopTag staining kit was performed on the sections. The peroxidase activity of the end-labeling was developed in substrate containing 20% 4-chloro-1-naphthol as a blue stain. Finally, the double-stained sections were mounted in Aquatex and observed by light microscopy.
Statistical Analysij
For quantitative comparison of the distribution of LPMs in different portions of the GI mucosa, the ratio of the number of LPMs to the number of overlying epithelial cells in the sections was calculated. Overlying epithelial cells were defined as cells aligned along the luminal surface at the top of each papilla of the lamina propria above the proliferating zone, as illustrated in Figure 1 . The proliferating zone was characterized by distinct PCNA (anti-proliferating cell nuclear antigen, clone PC10; Novocastra, Newcastle upon Tyne, UK) reactivity (Figure 1 ). The numbers of LPMs and of the overlying epithelial cells were counted in 10 randomly selected areas. and the ratio was calculated as count of LPMskount of overlying epithelial cells. The average proportions of three different individuals were compared. Statistical analysis was performed with the Kruskal-Wallis test, followed by Scheffe's F-test. mucosa typical macrophages that had round or oval nuclei and relatively abundant cytoplasm containing prominent phagocytosed vesicles or fragments, morphologically resembling so-called apoptotic bodies: Details are given below. Most of these macrophages accumulated beneath the epithelium covering the luminal surface of the LP. This distribution pattern was commonly seen in all examined mucosal specimens including gastric, duodenal, ileal, colon, and even fetal GI mucosa. Immunohistochemical examinations of LPMs revealed the phenotypes summarized in Table 2 . LPMs exhibited a marked reaction with 25F9 (Figure 2a ), which is believed to recognize a certain subpopulation of macrophages, anti-MHC Class I1 antigen (HLA-DR, DP, DQ) ( Figure 2b) , and CD74 (HLA invariant chain, LN-2). This reactivity was more intense than in other macrophages, including tingible body macrophages (TBMs), sinus macrophages in lymph nodes, splenic red pulp macrophages, alveolar macrophages, and Kupffer cells in the liver. In addition, the cells were labeled with antibodies known to react with ordinary macrophages, such as lysozyme, ferritin, ai-anti-trypsin, ai-anti-chymotrypsin, KP-1 (CD68) (Figure 2c ), and LN-5. These antigens were shared with other macrophages examined. LPMs did not demonstrate distinct reactivity with general myelomonocytic markers such as CD13, CD14, CD15, or CD33, or for dendritic cell markers such as CDla, CDlb, L-M2, or DF-DRC, in common with other macrophages. In addition, LPMs from the fetal GI tract demonstrated almost the same phenotype as those in the welldeveloped GI tract.
Results
Distribution ana' Im m uno histochemical Phenotypes of LPMs
Interestingly, some LPMs exhibited distinct reactivity for epithelial cell-associated antigens such as CEA (Figure 3 ), Ber-Ep4, and cytokeratin in their cytoplasm. These particular features were confined to LPMs, and none of the other macrophages in other organs observed exhibited any reactivity for these antigens.
In the duodenum, ileum, colon, and rectum, in a deeper part of the LP than that at which LPMs were located, there were some scattered dendrite-shaped cells without phagocytosed debris. These were positive for dendritic cell-associated antibodies such as IDC, GM2, CDla, CDlb, CDlc, and S-100 but were negative for 25F9. They were easily distinguishable from LPMs by their location, shape, and immunohistochemical features.
In Situ End-hbehg for Detection of Apoptotic Cells
Most of the fragments ingested by LPMs (apoptotic bodies) were strongly labeled in the mucosa of the stomach, duodenum, ileum, colon, and rectum by in situ end-labeling. Interestingly, some of the nuclei of epithelial cells covering the luminal surface of the LP demonstrated a positive reaction, although this was weaker than the reaction in LPMs. These positive fragments appeared to be exclusively ingested by LPMs. and no fragments were apparently located freely in the LP.
In positive control sections, all nuclei in GI mucosal cells, epithelial cells, mononuclear cells, and fibroblasts were labeled, in addition to granular staining in LPMs. A chromatin-related staining pattern was demonstrated in all nuclei. Negative control slides revealed no positive labeling. 
Double Staining with In Situ End-Labeling, Immunohistochemistry, and Restaining
Apoptotic bodies and cellular debris in the cytoplasm of LPMs were clearly visualized by in situ end-labeling for detection of apoptotic cells with the ApopTag kit, and some of these were simultaneously labeled by certain monoclonal antibodies against epithelial cellassociated antigens such as CEA, Ber-Ep4, and cytokeratin ( Figure  4 ). In addition, restaining with CD68 after Ber-Ep4 clearly showed that the cells containing epithelial cell-associated antigen were positive for macrophage-associated antigen (Figure 5 ) . These observations confirmed that LPMs ingest the components of apoptotic epithelial cells by phagocytosis.
ULtrastructuraL and Immunoelectron Mzcroscopic Features of LPMs
Conventional TEM observations indicated that LPMs in every region of the GI tract exhibited the typical ultrastructure of activated macrophages, having irregularly shaped euchromatic nuclei with some indentations and relatively abundant cytoplasm, including many phagocomes of various sizes. Some of these contained pyknotic nuclear fragments (apoptotic bodies) and cellular debris ( Figure  6 ). These morphological properties indicated active phagocytotic activity. Immunoelectron microscopic observations confirmed that LPMs expressed macrophage-associated antigens such as 25F9 (Figure 7a) , KP-1 and LN-5, MHC Class I1 antigens (HLA-DR) ( Figure   7b ), and MHC class 11-associated invariant chain CD74 (LN-2), either on their surface or in the cytoplasm. In addition, epithelial cell-associated antigens (CEA, Ber-Ep4, cytokeratin) were recognized in the cytoplasm of these cells ( Figures Sa and Sb) , as mentioned for LM observations. These reactivities were particularly apparent in the phagocytic vesicles or around the apopotic bodies. Sometimes these LPMs had pseudopod-like cytoplasmic processes containing apoptotic bodies, extending among epithelial cells. Moreover, immunoelectron microscopy demonstrated that LPMs were frequently in contact with CD3+, CD4+ lymphocytes.
In the deeper part of the LP of intestine, dendrite-shaped cells containing one or two nuclei were also observed by EM observation. Intriguingly, they had an interdigitating cell membrane, reminiscent of that of dendritic cells, and prominent reactivity for MHC Class I1 antigens on the membrane by immunoelectron microscopic observation. These cells were clearly distinguished from LPMs under EM observation. 
I I O
StatisticaL Comparison of Numbers of LPMs in &ch Portion of Human GI Mucosa
To compare the numbers of LPMs in each portion of human GI mucosa, the ratio of the LPM count to the overlying epithelial cell count was analyzed statistically. The comparisons indicated that LPMs were distributed most densely in colon and rectal mucosa and that the differences between the numbers of LPMs in the colon and rectum and those in other sites were statistically significant ( Figure 9 ). However, these were no significant differences in the distribution of LPMs between different areas of the colon, e.g., cecum, and the ascending, transverse, descending, and sigmoid colon.
Discussion
In this study, a number of specimens from human GI mucosa were examined systemitically by conventional light and electron microscopy and immunohistochemical labeling, using a panel of antibodies to define the cellular characteriktics and biological functions of LPMs. The following characteristic features of LPMs were identified: (a) the cells were distributed exclusively beneath the epithelium covering the upper surface of papillae in the LP or the tip of intestinal villi; (b) they contained many phagocytic vesicles, cellular debris, and apoptotic bodies; and (c) they exhibited some peculiar immunohistochemical features in comparison with representative macrophages distributed in other organs. One of these was their prominent reactivity with the monoclonal antibody (MAb) 25F9, which has been reported to discriminate a certain subpopulation of macrophages from blood monocytes, pulmonary alveolar macrophages, Kupffer cells in the liver, and most inflammatory exudate macrophages (18) (19) (20) . Further characterization of this MAb by Hume et al. (21) indicated that it reacts with macrophages that exhibit active endocytosis, such as TBMs in germinal centers and LPMs. Our present results support this observation. Indeed, our EM study indicates that 25F9 reacted with the membranes of phagocytic vesicles of phagosomes in the cytoplasm of LPM, as shown in Figure 7a . In other words, the distinct reactivity with 25F9 suggests that LPMs exhibit active endocytosis and phagocytosis.
Intense expression of MHC Class I1 molecules or related molecules on LPMs was also noted. Several other groups (22, 23) have also reported similar observations. It is well known that these molecules are expressed on antigen-presenting cells (APCs) and that they mediate the cellular contact between APCs and appropriate T-cells (24, 25) . In fact, our EM observations demonstrated close contact between CD4+, CD3' lymphocytes and LPMs, suggesting a possible antigen-presenting role of LPMs. Previous reports (5, 6) have also discussed this possibility. In contrast, Pavil et al. (26) did not identlfy any antigen-presenting capacity of LPMs in in vitro experiments with isolated LPMs and a mixed leukocyte reaction assay, and they concluded that dendritic cells, rather than macrophages, were the major APCs in LP. To determine whether or not LPMs have antigen-presenting functions and to elucidate the functional significance of the intense expression of MHC Class I1 and related molecules on LPMs, further experiments using in vitro assays or experimental animals will be required.
In this study we recognized distinct reactivity with antibodies against epithelial cell-associated antigens such as CEA, Ber-Ep4, and cytokeratin in LPMs. These reactivities were associated with the phagocytic vesicles or apoptotic bodies present in the cytoplasm of LPMs, as observed by EM, and with apoptotic nuclear fragments in LPMs, as shown by double staining using in situ end-labeling and immunohistochemsitry. These results show that LPMs obviously ingest apoptotic epithelial cells. Because of the large amount of phagocytic cellular debris in LPMs, many investigators have been interested in the types of cells that can be phagocytosed by LPMs, and several hypotheses on the subject have been proposed. Several authors have suggested that LPMs might ingest exogenous pathological antigens from the lumen of the GI tract to eliminate them (2) (3) (4) 6, 21) . However, the finding that many LPMS strongly expressing 25F9 accumulate at the tips of villi or on tops of papillae of the LP mucsoa, even in the fetal GI tract (27, 28) , which is believed to contain no exogenous or pathological substances or microorganisms, is inconsistent with this idea. On the other hand, Sawicki et al. (12) have proposed that LPMs might ingest intraepithelial lymphocytes or fibroblasts located in the LP. However, we were unable to find leukocyte-related antigens with phagocytic structures in the cytoplasm of LPMs. Recently, Iwanaga and colleagues (10, 11), on the basis of observations with experimental animals, proposed that LPMs might ingest and dispose of epithelial cells debris. Our results support this concept in the human system. In human GI mucosa, the generally accepted mechanism for the fate of epithelial cells is that newly developed epithelial cells move from the proliferative zone and finally fall into the lumen and into the murine mucosa (29,30). The renewal system in humans, proposed on the basis of our observations, is that epithelial cells undergo apoptosis at the tips of villi or in the uppermost regions of crypt and are then ingested by macrophages located in the LP just below them. Our immunoelectron microscopic studies demonstrated that apoptotic bodies were ingested in the cytoplasmic processes of LPMs extending into the epithelial layer, and we could not detect any apoptotic bodies that were not ingested by LPMs. Therefore, we believe that most apoptotic epithelial cells are phagocytosed intraepithelially.
Statistical analyses indicated that LPMs were most densely distributed in the colorectal mucosa. We have no explanation for this uneven distribution of LPMs, but the difference in the turnover duration of epithelial cells in each portion of the GI mucosa (30) (31) (32) or the more extensive bacterial flora in the colon from that in the small intestine in humans (33,34) may be involved. Similar observations regarding the distribution of LPMs at different sites of the GI tract have been reported in other experimental animals, including monkeys (10) and guinea pig (11) . In these animals, LPMs are most densely distributed in the small intestine. This discrepancy between humans and other animals might be explained by differences in dietary, bacterial, or digestive factors. The biological significance of the disposal of epithelial cells by LPMs is still obscure. However, the following two possibilities can be suggested: (a) regulation of epithelial renewal and prevention of excessive loss of constituent substances, and (b) elimination of maldeveloped or pathological epithelial cells. In certain pathological conditions, such as melanosis coli and Whipple's disease, significant alterations in LPMs have been reported (35-37). The relationship between the diseases and the LPMs may help to clarify the behavior of these cells. Further examinations of this aspect, using experimental systems and pathological specimens, are required.
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